AxSpA can bring on plantar fasciitis, which is when inflammation in the heel causes the sole of your foot to hurt. You may ...

Alcohol consumption was associated with lower levels of axSpA disease activity and spinal pain, but may be linked to ...

Acelyrin (NASDAQ:SLRN – Free Report) had its price target reduced by HC Wainwright from $8.00 to $6.00 in a research note released on Tuesday,Benzinga reports. They currently have a neutral rating on ...

TNF inhibitors offered greater protection against fractures than NSAIDs in patients with axial spondyloarthritis (axSpA).

Study finds TNF inhibitors lower hip and spine fracture risk in axial spondyloarthritis, addressing inflammation-related ...

New trials in three new indications have been initiated with the Nanobody® sonelokimab: Phase 3 VELA-TEEN trial in adolescent hidradenitis ...

High-dose nonsteroidal anti-inflammatory drug use among patients with axial spondyloarthritis (axSpA) may not increase the risk of developing hypertension, according to study results presented at the ...

and similarly what degree of peripheral involvement is allowed in classification of axial SpA. One or both sets of criteria may be fulfilled at different points in disease course, and this could ...

The following is a summary of “Association of Therapies for Axial Spondyloarthritis on the Risk of Hip and Spine Fractures,” published in the December 2024 issue of Rheumatology by Driscoll et al.

Derek Archila, an analyst from Wells Fargo, maintained the Buy rating on ACELYRIN, INC. (SLRN – Research Report). The associated price target ...

Acelyrin (NASDAQ:SLRN – Get Free Report) had its target price lowered by analysts at HC Wainwright from $8.00 to $6.00 in a ...